These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29878843)

  • 1. Discovery of a Tin-Piperonal-Entecavir Schiff Base Compound That Overcomes Multidrug Resistance by Inhibiting P-Glycoprotein.
    Zaman R; Ali G; Anjum Z; Sajid M; Khan MM; Ahmad A; Abbas SR; Rehman W
    Assay Drug Dev Technol; 2018; 16(4):205-211. PubMed ID: 29878843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.
    Ren Q; Yang G; Guo M; Guo J; Li Y; Lu J; Yang Q; Tang H; Li Y; Fang X; Sun Y; Qi JG; Tian J; Wang H
    Eur J Med Chem; 2019 Jan; 161():118-130. PubMed ID: 30347326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Potent Inhibitors against P-Glycoprotein-Mediated Multidrug Resistance Aided by Late-Stage Functionalization of a 2-(4-(Pyridin-2-yl)phenoxy)pyridine Analogue.
    Ma Y; Yin D; Ye J; Wei X; Pei Y; Li X; Si G; Chen XY; Chen ZS; Dong Y; Zou F; Shi W; Qiu Q; Qian H; Liu G
    J Med Chem; 2020 May; 63(10):5458-5476. PubMed ID: 32329342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological strategies for overcoming multidrug resistance.
    Nobili S; Landini I; Giglioni B; Mini E
    Curr Drug Targets; 2006 Jul; 7(7):861-79. PubMed ID: 16842217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of intrinsic and extrinsic apoptosis through oxidative stress in drug-resistant cancer by a newly synthesized Schiff base copper chelate.
    Banerjee K; Basu S; Das S; Sinha A; Biswas MK; Choudhuri SK
    Free Radic Res; 2016; 50(4):426-46. PubMed ID: 26733073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancer.
    Ganguly A; Chakraborty P; Banerjee K; Choudhuri SK
    Eur J Pharm Sci; 2014 Jan; 51():96-109. PubMed ID: 24044945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR).
    Teodori E; Dei S; Martelli C; Scapecchi S; Gualtieri F
    Curr Drug Targets; 2006 Jul; 7(7):893-909. PubMed ID: 16842220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schiff base derived from thiosemicarbazone and anthracene showed high potential in overcoming multidrug resistance in vitro with low drug resistance index.
    Bai J; Wang RH; Qiao Y; Wang A; Fang CJ
    Drug Des Devel Ther; 2017; 11():2227-2237. PubMed ID: 28814831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1.
    Rullo M; Niso M; Pisani L; Carrieri A; Colabufo NA; Cellamare S; Altomare CD
    Eur J Med Chem; 2019 Jan; 161():433-444. PubMed ID: 30384046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR).
    Teodori E; Dei S; Martelli C; Scapecchi S
    Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Yusof ENM; Latif MAM; Tahir MIM; Sakoff JA; Simone MI; Page AJ; Veerakumarasivam A; Tiekink ERT; Ravoof TBSA
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, and molecular structure of a novel zinc (II) complex: assessment of impact of MDR1Pgp expression on its cytotoxic activity.
    Harpstrite SE; Prior JL; Sivapackiam J; Collins SD; Rath NP; Sharma V
    Med Chem; 2010 Jul; 6(4):191-9. PubMed ID: 20843281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro.
    Banerjee K; Biswas MK; Choudhuri SK
    J Biol Inorg Chem; 2017 Dec; 22(8):1223-1249. PubMed ID: 29063196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of p-glycoprotein--lead identification and optimisation.
    Pleban K; Ecker GF
    Mini Rev Med Chem; 2005 Feb; 5(2):153-63. PubMed ID: 15720285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperonal: The Journey so Far.
    Akash J; Dushyant C; Jasmine C
    Mini Rev Med Chem; 2020; 20(18):1846-1856. PubMed ID: 32651966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
    Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives.
    Binkhathlan Z; Lavasanifar A
    Curr Cancer Drug Targets; 2013 Mar; 13(3):326-46. PubMed ID: 23369096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of a novel series of inhibitors reversing P-glycoprotein-mediated multidrug resistance.
    Ghaleb H; Li H; Kairuki M; Qiu Q; Bi X; Liu C; Liao C; Li J; Hezam K; Huang W; Qian H
    Chem Biol Drug Des; 2018 Sep; 92(3):1708-1716. PubMed ID: 29786944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.